Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 2;11(12):e055169.
doi: 10.1136/bmjopen-2021-055169.

Establishing a sentinel surveillance system for the novel COVID-19 in a resource-limited country: methods, system attributes and early findings

Affiliations

Establishing a sentinel surveillance system for the novel COVID-19 in a resource-limited country: methods, system attributes and early findings

Pritimoy Das et al. BMJ Open. .

Abstract

Objectives: To establish a hospital-based platform to explore the epidemiological and clinical characteristics of patients screened for COVID-19.

Design: Hospital-based surveillance.

Setting: This study was conducted in four selected hospitals in Bangladesh during 10 June-31 August 2020.

Participants: In total, 2345 patients of all age (68% male) attending the outpatient and inpatient departments of surveillance hospitals with any one or more of the following symptoms within last 7 days: fever, cough, sore throat and respiratory distress.

Outcome measures: The outcome measures were COVID-19 positivity and mortality rate among enrolled patients. Pearson's χ2 test was used to compare the categorical variables (sign/symptoms, comorbidities, admission status and COVID-19 test results). Regression analysis was performed to determine the association between potential risk factors and death.

Results: COVID-19 was detected among 922 (39%) enrolled patients. It was more common in outpatients with a peak positivity in second week of July (112, 54%). The median age of the confirmed COVID-19 cases was 38 years (IQR: 30-50), 654 (71%) were male and 83 (9%) were healthcare workers. Cough (615, 67%) was the most common symptom, followed by fever (493, 53%). Patients with diabetes were more likely to get COVID-19 than patients without diabetes (48% vs 38%; OR: 1.5; 95% CI: 1.2 to 1.9). The death rate among COVID-19 positive was 2.3%, n=21. Death was associated with age ≥60 years (adjusted OR (AOR): 13.9; 95% CI: 5.5 to 34), shortness of breath (AOR: 9.7; 95% CI: 3.0 to 30), comorbidity (AOR: 4.8; 95% CI: 1.1 to 21.7), smoking history (AOR: 2.2, 95% CI: 0.7 to 7.1), attending the hospital in <2 days of symptom onset due to critical illness (AOR: 4.7; 95% CI: 1.2 to 17.8) and hospital admission (AOR: 3.4; 95% CI: 1.2 to 9.8).

Conclusions: COVID-19 positivity was observed in more than one-third of patients with suspected COVID-19 attending selected hospitals. While managing such patients, the risk factors identified for higher death rates should be considered.

Keywords: COVID-19; diagnostic microbiology; epidemiology; public health.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Location of the study hospitals and proportionate distribution of enrolled patients at different sites with their COVID-19 positivity, June to August 2020
Figure 2
Figure 2
SARS-CoV-2 infection among suspected COVID-19 patients at inpatient and outpatient departments of selected hospitals during June to August 2020, Bangladesh. A. Detection of SARS-CoV-2 at all four selected hospitals over time. B. Detection of SARS-CoV-2 at inpatient and outpatient departments of selected hospital sites. rRT-PCR, real-time reverse transcription-PCR.
Figure 3
Figure 3
Distribution of SARS-CoV-2 infected patients by their clinical features and comorbidity in selected hospitals of Bangladesh, June-August 2020. A. Presenting symptoms of all COVID-19 suspected patients by rRT-PCR results. B. Presenting symptoms of COVID-19 patients by department. C. COVID-19 positive patients by their comorbidity.

Similar articles

Cited by

References

    1. Cheng ZJ, Shan J. 2019 novel coronavirus: where we are and what we know. Infection 2020;48:155–63. 10.1007/s15010-020-01401-y - DOI - PMC - PubMed
    1. Worldometer . Coronavirus update (live): cases and deaths from COVID-19 virus pandemic. Available: https://www.worldometers.info/coronavirus/ [Accessed 1 Apr 2021].
    1. Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020;395:497–506. 10.1016/S0140-6736(20)30183-5 - DOI - PMC - PubMed
    1. Leung C. Clinical features of deaths in the novel coronavirus epidemic in China. Rev Med Virol 2020;30:e2103. 10.1002/rmv.2103 - DOI - PMC - PubMed
    1. Hassan SA, Sheikh FN, Jamal S, et al. . Coronavirus (COVID-19): a review of clinical features, diagnosis, and treatment. Cureus 2020. 10.7759/cureus.7355 - DOI - PMC - PubMed

Publication types